缅北禁地

Asra holds a PhD in Health Economics and Policy and an MSc in Health Technology Assessment. She is a Senior Health Economist with over a decade of experience in health technology assessment (HTA), economic evaluation, and decision-analytic modelling to inform health policy and resource allocation. She has extensive expertise in developing de novo cost-effectiveness and budget impact models, critically appraising industry submissions, and delivering evidence reviews for national decision-making bodies.

Asra is currently contributing to high-quality evidence synthesis and economic evaluation to support NICE technology appraisals across diagnostics, therapeutics, and public health interventions. Her work spans single and multiple technology appraisals, diagnostic assessment reports, and real-world NHS service evaluations.

Prior to joining 缅北禁地, Asra held academic and research positions at the Universities of Bristol and Warwick, contributing to NICE Evidence Review Group work and supervising postgraduate students in health economics and HTA. At the University of Bristol, she was part of the NIHR Health Protection Research Unit (HPRU), collaborating closely with infectious disease modellers on economic evaluations for blood-borne virus testing, HIV, hepatitis C, and emergency department screening interventions. She has led and contributed to projects funded by NIHR, NHS England, UKHSA, and international partners, with applications across infectious diseases, AI-enabled diagnostics, screening programmes, and service delivery redesign.

She has published widely in peer-reviewed journals and regularly presents at national and international conferences. In addition to her research role, Asra is actively involved in teaching and supervision in health economics and HTA and is committed to capacity building within both academic and applied policy settings.

• Articles

  • Walker, JG, Baggaley, RF, Myring, G, Irvine, MA, Asgharzadeh, A, Laurence, YV, Bell, E, Schoemig, V, Cross, E, Allison, S, Kundu, B, McNaughton, AL, Todd, R, Heath, R, Ward, Z, May, T, Hill-Tout, R, Hindle, S, Spencer, N, Bowman, C, Jackson, I, Horwood, J, Desai, M, Vickerman, P, Djuretic, T, Hickman, M, Mandal, S. Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling study. 2026. Submitted.
  • Simmons R, Powell AA, Ijaz S, Mandal S, Shute J, Mohammadi Y, Lattimore M, McOwat K, Moore HL, O'Rourke A, Desai M, Macleod J, Asgharzadeh A, Ward Z, Vickerman P, Harris RJ, Foster GR, Roberts K, Hickman M. . British Journal of General Practice 2025, 75(751), e122-e128.

• Reports

  • Geppert J, Auguste P, Asgharzadeh A, Ghiasvand H, Patel M, Brown A, Jayakody S, Helm E, Todkill D, Madan J, Stinton C, Gallacher D, Taylor-Phillips S, Chen YF. . NIHR Evidence Synthesis Programme on behalf of the National Institute for Health and Care Excellence, 2022.
  • Asgharzadeh, A, Patel, M, Connok, M, Dmery, S, Ghosh, I, Jordan, M, Momanyi, K, Freeman, K, Brown, A, Baldwin, S, Ogunlayi, F, Stinton, C, Cummins, E, Al-Khudairy, L. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. 2022.

• Reviews

  • Geppert J, Auguste P, Asgharzadeh A, Ghiasvand H, Patel M, Brown A, Jayakody S, Helm E, Todkill D, Madan J, Stinton C, Gallacher D, Taylor-Phillips S, Chen Y-F. . Health Technology Assessment 2025, 29(14).
  • Asgharzadeh A, Patel M, Connock M, Damery S, Ghosh I, Jordan M, Freeman K, Brown A, Court R, Baldwin S, Ogunlayi F, Stinton C, Cummins E, Al-Khudairy L. . Health Technology Assessment 2024, 28(80).
  • Burch E, Khan SA, Stone J, Asgharzadeh A, Dawe J, Ward Z, Brooks-Pollock E, Christensen H. . Public Health 2024, 236, 207-215.
  • Asgharzadeh A, Shabaninejad H, Aryankhesal A, Majdzadeh R. . Evidence & Policy: a journal of research, debate and practice 2021, 17(1), 29–57.